What Is GMP in an IPO? A Plain-English Guide
Grey market premium explained — what it measures, why it moves daily, and how much weight to actually give it before applying.
Published on · Verified Analysis
Editorial Key Takeaways
This analysis is based on official Draft Red Herring Prospectus (DRED) filings, historical peer valuation multiples, and exchange data. Figures are audited for institutional accuracy.
In This Article
Every IPO season, the same number gets quoted in every WhatsApp group before anything else: the GMP. It is the first thing people look up and, too often, the only thing they look at.
This guide explains what that number actually is, where it comes from, and — the part usually left out — how much of your decision it deserves to carry.
What GMP actually means
GMP is short for grey market premium. It is the amount, per share, that someone in an unofficial market is willing to pay *above* the IPO's issue price, for shares that have not listed yet.
The arithmetic is deliberately simple:
Expected listing price = Issue price + GMP
If an IPO is priced at ₹300 and the GMP is ₹60, the grey market is implying a listing around ₹360 — a 20% premium. On this site that percentage is shown next to the rupee figure, because ₹60 means something very different on a ₹300 issue than on a ₹1,500 one.
That is the whole formula. The complexity is not in the maths — it is in what the number is worth.
Where the grey market lives
The "grey market" is not a place, an app, or an exchange. It is an informal network of dealers, mostly concentrated in a few trading hubs, who quote two-way prices on IPOs that have not listed.
Three things follow from that, and they matter more than most people realise:
That last point is the one to keep hold of. A number set by a small group on thin volume can be moved cheaply — and sometimes is, by people who benefit from the impression of heavy demand.
The three prices people confuse
GMP is one of three grey market quotes, and they are routinely mixed up. They answer genuinely different questions.
| Term | What is being traded | When you get paid |
|---|---|---|
| **GMP** | The shares themselves | On listing, settled against the actual listing price |
| **Kostak** | Your whole application | Up front — regardless of whether you are allotted |
| **Subject to Sauda** | Your whole application | Only if your application is actually allotted |
Kostak is effectively selling your lottery ticket for a fixed, guaranteed fee. If you sell an application for a ₹800 Kostak, you receive ₹800 whether you get zero shares or a full lot. You have converted an uncertain outcome into a small certain one — and capped your upside doing it.
Subject to Sauda pays more than Kostak, because the buyer only pays when the application actually wins something. You are keeping the allotment risk and selling the listing-gain upside.
GMP is the underlying sentiment number that drives the other two.
Why the number moves every day
GMP is not a fixed estimate published once. It is a live price, and it responds to:
None of those inputs is the company's business. That is the crucial observation: GMP measures expected short-term demand, not value.
How reliable is it, honestly
Directionally, GMP is reasonably useful. When it is strongly positive, issues usually do list at a premium. When it is negative or near zero, muted listings are common. As a rough sentiment gauge it earns its place.
As a *price forecast*, it is much weaker, and it fails in a specific, predictable pattern:
1. It overshoots on hyped issues. The bigger the retail frenzy, the more GMP tends to run ahead of where the stock actually lists. The cases where the number is most exciting are the cases where it is least trustworthy.
2. It is stalest right before listing. GMP is quoted until the last moment, but the market that determines the real opening price — institutions placing real orders at scale — is not the market setting the GMP.
3. It cannot see a bad tape. GMP quoted on a calm Tuesday tells you nothing about a listing that happens after a 2% gap-down on Thursday.
A useful mental reframing: GMP is closer to a betting line than a valuation. It tells you what the crowd expects. It does not tell you what something is worth, and the crowd is not always right.
How to actually use it
GMP is a legitimate input. It is not a decision. A reasonable way to hold it:
The mistakes worth avoiding
Treating GMP as guaranteed. It is an unregulated quote, not a commitment from anyone. There is no mechanism that makes a stock list at issue price plus GMP.
Chasing one source. GMP quotes differ between dealers and between sites. A single suspiciously precise number should make you more sceptical, not less.
Ignoring the lock-in maths. A ₹60 GMP on a lot you may not even be allotted is not ₹60 in your pocket. Multiply by the realistic probability of allotment before it feels like money.
Forgetting the downside is real. Issues do list below their price band. A positive GMP right up to listing day has never prevented that.
The short version
GMP is a live, unregulated sentiment price for IPO shares before they list, set by a small group of dealers on thin volume. It is genuinely useful as one signal among several, and genuinely dangerous as a substitute for reading the prospectus.
Use it to understand what the market currently expects. Use the financials to decide whether the market is right.
*Nothing here is investment advice. IPO investing carries risk, including the risk of listing below the issue price. Consult a SEBI-registered adviser before investing.*
About IPOSathi Research
Primary Market Analyst & Senior Financial Journalist · IPO Latest Updates Daily
Our research desk specializes in reading SEBI Red Herring Prospectuses, institutional anchor allocations, and forensic balance sheet audits. Every report follows rigorous E-E-A-T research standards without promoter sponsorship.